Antiphospholipid antibody formation during immune checkpoint inhibition in patients with cancer: a prospective cohort study
Anniek Strijdhorst, Dorien M. Salet, Jente M Schoenaker, Vossa van der Vegte et autres
Background: Immune checkpoint inhibitors (ICIs) significantly improve survival in many cancer types. However, ICIs are associated with an increased risk of venous and arterial thromboembolism, and the underlying mechanisms are incompletely understood. We hypothesized that ICI therapy may induce the development of …
nl (code pays fourni par la source)
0 citations
Research and Practice in Thrombosis and Haemostasis